Impact of hepatocyte-specific deletion of staphylococcal nuclease and tudor domain containing 1 (SND1) on liver insulin resistance and acute liver failure of mice

References

• Gutierrez-Beltran E, Denisenko TV, Zhivotovsky B, et al. Tudor staphylococcal nuclease: biochemistry and functions. Cell Death Differ. 2016;23(11):1739–1748.
   PubMed Web of Science ®Google Scholar
• Shaw N, Zhao M, Cheng C, et al. The multifunctional human p100 protein ‘hooks’ methylated ligands. Nat Struct Mol Biol. 2007;14(8):779–784.
   PubMed Web of Science ®Google Scholar
• Duan Z, Zhao X, Fu X, et al. Tudor-SN, a novel coactivator of peroxisome proliferator-activated receptor gamma protein, is essential for adipogenesis. J Biol Chem. 2014;289(12):8364–8374.
   PubMed Web of Science ®Google Scholar
• Gao X, Fu X, Song J, et al. Poly(A)(+) mRNA-binding protein Tudor-SN regulates stress granules aggregation dynamics. FEBS J. 2015;282(5):874–890.
   PubMed Web of Science ®Google Scholar
• Gao X, Zhao X, Zhu Y, et al. Tudor staphylococcal nuclease (Tudor-SN) participates in small ribonucleoprotein (snRNP) assembly via interacting with symmetrically dimethylated Sm proteins. J Biol Chem. 2012;287(22):18130–18141.
   PubMed Web of Science ®Google Scholar
• Su C, Zhang C, Tecle A, et al. Tudor staphylococcal nuclease (Tudor-SN), a novel regulator facilitating G1/S phase transition, acting as a co-activator of E2F-1 in cell cycle regulation. J Biol Chem. 2015;290(11):7208–7220.
   PubMed Web of Science ®Google Scholar
• Yu L, Liu X, Cui K, et al. SND1 acts downstream of TGFbeta1 and upstream of Smurf1 to promote breast cancer metastasis. Cancer Res. 2015;75(7):1275–1286.
   PubMed Web of Science ®Google Scholar
• Su C, Gao X, Yang W, et al. Phosphorylation of Tudor-SN, a novel substrate of JNK, is involved in the efficient recruitment of Tudor-SN into stress granules. Biochim Biophys Acta Mol Cell Res. 2017;1864(3):562–571.
   PubMed Web of Science ®Google Scholar
• Fu X, Zhang C, Meng H, et al. Oncoprotein Tudor-SN is a key determinant providing survival advantage under DNA damaging stress. Cell Death Differ. 2018;25(9):1625–1637.
   PubMed Web of Science ®Google Scholar
• Yang J, Valineva T, Hong J, et al. Transcriptional co-activator protein p100 interacts with snRNP proteins and facilitates the assembly of the spliceosome. Nucleic Acids Res. 2007;35(13):4485–4494.
   PubMed Web of Science ®Google Scholar
• Gao X, Ge L, Shao J, et al. Tudor-SN interacts with and co-localizes with G3BP in stress granules under stress conditions. FEBS Lett. 2010;584(16):3525–3532.
   PubMed Web of Science ®Google Scholar
• Cui X, Zhao C, Yao X, et al. SND1 acts as an anti-apoptotic factor via regulating the expression of lncRNA UCA1 in hepatocellular carcinoma. RNA Biol. 2018;15(10):1364–1375.
   PubMed Web of Science ®Google Scholar
• Wang X, Xin L, Duan Z, et al. Global Tudor-SN transgenic mice are protected from obesity-induced hepatic steatosis and insulin resistance. FASEB J. 2019;33(3):3731–3745.
   PubMed Web of Science ®Google Scholar
• Haeusler RA, McGraw TE, Accili D. Biochemical and cellular properties of insulin receptor signalling. Nat Rev Mol Cell Biol. 2018;19(1):31–44.
   PubMed Web of Science ®Google Scholar
• Lebeaupin C, Vallee D, Hazari Y, et al. Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J Hepatol. 2018;69(4):927–947.
   PubMed Web of Science ®Google Scholar
• Yin J, Ding J, Huang L, et al. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression. Anat Rec (Hoboken). 2013;296(10):1568–1575.
   PubMedGoogle Scholar
• Yoo BK, Santhekadur PK, Gredler R, et al. Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma. Hepatology. 2011;53(5):1538–1548.
   PubMed Web of Science ®Google Scholar
• Jariwala N, Rajasekaran D, Mendoza RG, et al. Oncogenic role of SND1 in development and progression of hepatocellular carcinoma. Cancer Res. 2017;77(12):3306–3316.
   PubMed Web of Science ®Google Scholar
• Palacios L, Ochoa B, Gomez-Lechon MJ, et al. Overexpression of SND p102, a rat homologue of p100 coactivator, promotes the secretion of lipoprotein phospholipids in primary hepatocytes. Biochim Biophys Acta. 2006;1761(7):698–708.
   PubMed Web of Science ®Google Scholar
• Garcia-Arcos I, Rueda Y, Gonzalez-Kother P, et al. Association of SND1 protein to low density lipid droplets in liver steatosis. J Physiol Biochem. 2010;66(1):73–83.
   PubMed Web of Science ®Google Scholar
• Bernal W, Wendon J. Acute liver failure. N Engl J Med. 2013;369(26):2525–2534.
   PubMed Web of Science ®Google Scholar
• Wang T, Wang Z, Yang P, et al. PER1 prevents excessive innate immune response during endotoxin-induced liver injury through regulation of macrophage recruitment in mice. Cell Death Dis. 2016;7(4):e2176.
   PubMedGoogle Scholar
• Thawley V. Acute Liver Injury and Failure. Vet Clin North Am Small Anim Pract. 2017;47(3):617–630.
   PubMed Web of Science ®Google Scholar
• Gao X, Zhao C, Zhang N, et al. Genetic expression and mutational profile analysis in different pathologic stages of hepatocellular carcinoma patients. BMC Cancer. 2021;21(1):786.
   PubMed Web of Science ®Google Scholar
• Cui X, Zhang X, Liu M, et al. A pan-cancer analysis of the oncogenic role of staphylococcal nuclease domain-containing protein 1 (SND1) in human tumors. Genomics. 2020;112(6):3958–3967.
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16(5):284–287.
   PubMed Web of Science ®Google Scholar
• Yang Y, Long X, Li G, et al. Prediction of clinical prognosis in cutaneous melanoma using an immune-related gene pair signature. Bioengineered. 2021;12(1):1803–1812.
   PubMed Web of Science ®Google Scholar
• Mackenzie RW, Elliott BT. Akt/PKB activation and insulin signaling: a novel insulin signaling pathway in the treatment of type 2 diabetes. Diabetes Metab Syndr Obes. 2014;7:55–64.
   PubMedGoogle Scholar
• Navarro-Imaz H, Rueda Y, Fresnedo O. SND1 overexpression deregulates cholesterol homeostasis in hepatocellular carcinoma. Biochim Biophys Acta. 2016;1861(9 Pt A):988–996.
   PubMed Web of Science ®Google Scholar
• Chen L, Chen XW, Huang X, et al. Regulation of glucose and lipid metabolism in health and disease. Sci China Life Sci. 2019;62(11):1420–1458.
   PubMed Web of Science ®Google Scholar
• Navarro-Imaz H, Chico Y, Rueda Y, et al. Channeling of newly synthesized fatty acids to cholesterol esterification limits triglyceride synthesis in SND1-overexpressing hepatoma cells. Biochim Biophys Acta Mol Cell Biol Lipids. 2019;1864(2):137–146.
   PubMed Web of Science ®Google Scholar
• Santos CR, Schulze A. Lipid metabolism in cancer. FEBS J. 2012;279(15):2610–2623.
   PubMed Web of Science ®Google Scholar
• Jirillo E, Caccavo D, Magrone T, et al. The role of the liver in the response to LPS: experimental and clinical findings. J Endotoxin Res. 2002;8(5):319–327.
   PubMedGoogle Scholar
• Wu Z, Han M, Chen T, et al. Acute liver failure: mechanisms of immune-mediated liver injury. Liver Int. 2010;30(6):782–794.
   PubMed Web of Science ®Google Scholar
• Claria J, Arroyo V, Moreau R. The acute-on-chronic liver failure syndrome, or when the innate immune system goes astray. J Immunol. 2016;197(10):3755–3761.
   PubMed Web of Science ®Google Scholar
• Kitazawa T, Tsujimoto T, Kawaratani H, et al. Therapeutic approach to regulate innate immune response by Toll-like receptor 4 antagonist E5564 in rats with D-galactosamine-induced acute severe liver injury. J Gastroenterol Hepatol. 2009;24(6):1089–1094.
   PubMed Web of Science ®Google Scholar
• Arretxe E, Armengol S, Mula S, et al. Profiling of promoter occupancy by the SND1 transcriptional coactivator identifies downstream glycerolipid metabolic genes involved in TNFalpha response in human hepatoma cells. Nucleic Acids Res. 2015;43(22):10673–10688.
   PubMed Web of Science ®Google Scholar
• Santhekadur PK, Das SK, Gredler R, et al. Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor kappaB and miR-221. J Biol Chem. 2012;287(17):13952–13958.
   PubMed Web of Science ®Google Scholar
• Armengol S, Arretxe E, Rodriguez L, et al. NF-kappaB, Sp1 and NF-Y as transcriptional regulators of human SND1 gene. Biochimie. 2013;95(4):735–742.
   PubMed Web of Science ®Google Scholar
• Mencin A, Kluwe J, Schwabe RF. Toll-like receptors as targets in chronic liver diseases. Gut. 2009;58(5):704–720.
   PubMed Web of Science ®Google Scholar
• Heymann F, Tacke F. Immunology in the liver–from homeostasis to disease. Nat Rev Gastroenterol Hepatol. 2016;13(2):88–110.
   PubMed Web of Science ®Google Scholar